Redox chemistry of the 9-anilinoacridine class of antitumor agents
Authors:
- Jeffrey L. JurlinaJJJeffrey L. Jurlina
- Andrew LindsayALAndrew Lindsay
- John E. PackerJPJohn E. Packer
- Bruce C. BaguleyBBBruce C. Baguley
- William A. DennyWDWilliam A. Denny
- 1 March 1987
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 30 (3) , 473-480
Abstract
9-Anilinoacridines bearing a 1''-NHR substituent on the anilino ring undergo facile, chemically reversible, two-electron oxidation to quinone diimines. The chemical and electrochemical oxidation of three groups of 9-anilinoacridines (1''-substituted derivatives, together with 3''-substituted analogues and acridine-substituted analogues of the clinical antileukemic drug amsacrine) have been studied and their redox potentials determined. For aniline-substituted derivatives, redox potentials (E1/2) correlate well with substituent electronic properties, with electron-donating substituents facilitating oxidation. Substituents in the acridine ring have little effect on redox potentials, indicating minimal transmission of electronic effects from the acridine to the aniline rings. Although the broad class of 9-anilinoacridines show biological activity over a very wide range of structural variations, a 1''-NHR substituent is a common feature of the most active derivatives. Nevertheless, no clear quantitative relationships between redox potential and biological activity could be discerned, and the relevance of this redox chemistry to the mode of action of amsacrine and other 9-anilinoacridines remains unclear.Keywords
This publication has 18 references indexed in Scilit:
- Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.Proceedings of the National Academy of Sciences, 1984
- Potential antitumor agents. 41. Analogs of amsacrine with electron-donor substituents in the anilino ringJournal of Medicinal Chemistry, 1984
- Potential antitumor agents. 39. Anilino ring geometry of amsacrine and derivatives: relationship to DNA binding and antitumor activityJournal of Medicinal Chemistry, 1983
- o-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetateJournal of Medicinal Chemistry, 1983
- Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agentsJournal of Medicinal Chemistry, 1982
- COMPARISON OF THE INVIVO AND INVITRO ANTILEUKEMIC ACTIVITY OF MONOSUBSTITUTED DERIVATIVES OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE1982
- Identification of the principal biliary metabolite of 4'-(9-acridinylamino)methanesulfon-m-anisidide in rats.Drug Metabolism and Disposition, 1982
- Potential antitumor agents. 35. Quantitative relationships between antitumor (L1210) potency and DNA binding for 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) analogsJournal of Medicinal Chemistry, 1981
- Qualitative and quantitative aspects of intercalator-induced DNA strand breaksBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1979
- Potential antitumor agents. 26. Anionic congeners of the 9-anilinoacridinesJournal of Medicinal Chemistry, 1978